Searched for
CADILA STOCK
Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Will three-dose Covid vaccine give Cadila Healthcare a booster shot?Analysts do see a lift to its sales, even as some of them are not factoring in sales beyond FY23 amid uncertainty over booster shots. The p...
- Buy Cadila Healthcare, target Rs 315: Nirmal Bang SecuritiesCadila Healthcare is a largecap company, operating in pharmaceuticals and health care sector.
- Stock pick of the week: What makes Cadila Healthcare analysts top betBetter than expected sales and net profit growth, limited impact of US FDA due to its limited exposure, and among other things, have made i...
- Cadila Healthcare gets EIR from USFDA for Moraiya facility"What is 'closed' is the initial review that resulted in the warning letter issuance," Cadila Healthcare said.
- Buy Cadila Healthcare with an intraday target at Rs 350: Gaurav Bissa, LKP SecuritiesGaurav Bissa of LKP Securities recommends buy rating on Cadila Healthcare with a target of Rs 350 and a strict stop loss of Rs 310
- Cadila Healthcare to delist from Ahmedabad Stock Exchange, will remain listed on BSE and NSEThe company's board, which met today, decided to delist equity shares of the company from ASE, Cadila Healthcare said in a filing to the BS...
- Cadila Healthare shares surge nearly 6% on smart earningsShares of Cadila Healthcare today surged nearly 6 per cent after pharma firm reported 81.54 per cent increase in consolidated net profit fo...
- Warner Chilcott & Cadila Healthcare settles patent litigationIndia's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.
- Zydus Cadila Group to merge its three subsidiaries with its listed entity Cadila Healthcare LtdIn 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...
- Stock Buzz: Persistent Systems, Cadila top investment ideasInvestors should align themselves with businesses which are export oriented, and with companies which will benefit if rupee depreciates.
- Zydus Cadila gets approval for Doxepin Hcl, to launch in 2020The estimated sales in 2012 as per IMS for Doxepin Hcl, which falls in the neuropsychiatry segment, was $15.5 million, as per company.
- Cadila stock touches 52 week high after gettting USFDA approval for two generic drugsAccording to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...
- Uptrend for Cadila Healthcare: Ashwani GujralIt's a stock which creates alpha, meaning regardless of market movement, it generally tends to move on the upside.
- Cadila launches Parkinson's generic drug in the US marketCadila Healthcare said it has launched generic Pramipexole tablets, used for treating Parkinson's disease, in the US market.
- HC rejects Cadila plea for exclusive use of 'sugar free' tagThe Delhi High Court has turned down the plea of drug firm Cadila healthcare seeking to restrain Diat Foods from using the 'sugar free' tag...
- Cadila is the pick of the pharma pack: Deepak MohoniDeepak Mohoni, director, trendwatchindia.com, in a chat with ET Now talks about the pharma stocks.
- Cadila shareholders approve share swap for biz restructuringPharmaceutical firm Cadila Healthcare said its shareholders have approved the restructuring of its consumer products division as subsidiary...
Load More
